DotBio is a biopharmaceutical company specialized in next-generation domain antibody therapies.
Location: United States, North Carolina, Weddington
Total raised: $5.6M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.08.2023 | - | $5.6M | Gaorong Ca... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 10.08.2023 | DotBio Raises USD 5.6M in Pre-A Financing | DotBio, a Singapore-based biopharmaceutical company advancing antibody therapeutic modalities to bri... | finsmes.co... |
| 10.08.2023 | Deals in brief: Meatable secures USD 35 million in funding, ... | Meatable raises USD 35 million in its latest funding round The Netherlands-based food tech company h... | kr-asia.co... |
| 08.08.2023 | Deals in brief: Disprz and DotBio secure new funding, South ... | Disprz secures USD 30 million in Series C round The India-based enterprise software-as-a-service lea... | kr-asia.co... |
| 09.11.2021 | CStone Pharmaceuticals and DotBio sign a global discovery co... | The two sides will jointly develop up to three preclinical first-in-class or best-in-class next-gene... | en.prnasia... |
| 10.03.2021 | Uni-Bio Science Group and DotBio Announce Partnership to Co-... | HONG KONG SAR – EQS Newswire – 10 March 2021 – A fully integrated biopharmaceutical company — Uni-Bi... | africanews... |